07/26/2021 17:02
Clarín.com
Society
Updated 07/26/2021 17:05
The doses of
Moderna
will be included in the study of combined schemes carried out by the Ministry of Health to authorize heterologous vaccination schemes against the coronavirus, that is, the possibility of using vaccines from different laboratories in the same immunization.
This was confirmed by the portfolio led by Carla Vizzotti in a statement released this Monday.
"We have defined the incorporation of the Moderna vaccine in the studies that seek to
determine the safety and immunity in the combination
of vaccines," said Minister Vizzotti, adding that "advancing in the production of scientific evidence in this regard is very important in order to have a
greater
range
of possibilities
to achieve complete (vaccination) schedules in the shortest possible time ”.
The study in question is "collaborative and federal", and is coordinated with the participating jurisdictions (Buenos Aires, Córdoba, La Rioja, Mendoza and San Luis) and researchers from the National Council for Scientific and Technical Research (CONICET).
Minister Carla Vizzotti, upon receiving doses of the Chinese Sinopharm vaccine, at the Ezeiza airport.
Photo Marcelo Carroll
The scientific work seeks "to have national evidence for decision-making based on the analysis of immunogenicity and safety of the use of different doses in the same scheme," as specified in the official statement.
So far, the dose combinations of AstraZeneca, the Chinese Sinopharm and the Russian Sputnik-V were under study, the latter presenting the longest delay for second applications.
Moderna's vaccines came to the country through a donation from the United States government.
There are 3.5 million doses.
News in development.
DS
Look also
More than 800 thousand doses of the AstraZeneca vaccine arrive and Argentina is close to 42 million doses received
Sputnik V vaccine shows efficacy against Alpha variant, but decreases against Beta
